Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Publications from the Centre for Immuno-Oncology

Routing immunomodulatory cytokine-encoded mRNAs to the omentum: turning an enemy into an ally in peritoneal metastasis

Arrizabalaga L. et al, (2025), OncoImmunology, 14

Association of PD-1, LAG-3 and TIM-3 expression on intratumoral CD8 T-cells with response to atezolizumab in a Real-World-Evidence biomarker study for advanced urothelial carcinoma patients.

de Andrea CE. et al, (2025), Oncoimmunology, 14

Dimension reduction in quantum sampling of stochastic processes

Yang C. et al, (2025), npj Quantum Information, 11

The long-lasting expression of recombinant artLCMV following intraperitoneal administration exerts potent antitumor effects on tumor models of peritoneal carcinomatosis.

Gomar C. et al, (2025), Oncoimmunology, 14

Genome-wide association and gene-virus interaction study of liver disease in hepatitis C virus-infected patients

Quistrebert J. et al, (2025)

Targeting MHC-E as a new strategy for vaccines and immunotherapeutics

Frueh K. et al, (2025), Nature Reviews Immunology

Adsorption of antigen to polymeric nanoparticles enhances cytotoxic T-cell responses and anti-tumor immunity by targeting conventional type 1 dendritic cells.

Huete-Carrasco J. et al, (2025), Immunology and cell biology

Nanotechnology for immuno-oncology.

Grippin AJ. et al, (2025), Nature cancer

T cell engagers: expanding horizons in oncology and beyond.

Albayrak G. et al, (2025), Br J Cancer

Atom-level mechanism of tapasin-independent peptide editing by Major Histocompatibility Complex class I molecules

Turner S. et al, (2025)

Antigen-presenting mast cells are new players in breast cancer immunotherapy.

Luri-Rey C. et al, (2025), Nature medicine

Dual ENPP1/ATM depletion blunts DNA damage repair boosting radioimmune efficacy to abrogate triple-negative breast cancer.

Ruiz-Fernández de Córdoba B. et al, (2025), Signal transduction and targeted therapy, 10

In vivo labelling resolves distinct temporal, spatial, and functional properties of tumour macrophages, and identifies subset-specific effects of PD-L1 blockade.

Lee CY. et al, (2025), Cancer immunology research

Strict advantage of complex quantum theory in a communication task

Elliott TJ., (2025), Physical Review A, 111

Phase II study of perioperative Avelumab plus chemotherapy for patients with resectable gastric cancer or gastroesophageal junction cancer - the MONEO Study.

Alsina M. et al, (2025), Clin Cancer Res

Supplemental Figure 2 from Dynamic Tracking of Tumor Microenvironment Modulation Using Kaede Photoconvertible Transgenic Mice Unveils New Biological Properties of Viral Immunotherapy

Diers AR. et al, (2025)

Supplemental Figure 3 from Dynamic Tracking of Tumor Microenvironment Modulation Using Kaede Photoconvertible Transgenic Mice Unveils New Biological Properties of Viral Immunotherapy

Diers AR. et al, (2025)

Supplemental Figure 4 from Dynamic Tracking of Tumor Microenvironment Modulation Using Kaede Photoconvertible Transgenic Mice Unveils New Biological Properties of Viral Immunotherapy

Diers AR. et al, (2025)

Supplemental Figure 5 from Dynamic Tracking of Tumor Microenvironment Modulation Using Kaede Photoconvertible Transgenic Mice Unveils New Biological Properties of Viral Immunotherapy

Diers AR. et al, (2025)

Supplementary Figure S1 from Dynamic Tracking of Tumor Microenvironment Modulation Using Kaede Photoconvertible Transgenic Mice Unveils New Biological Properties of Viral Immunotherapy

Diers AR. et al, (2025)

Load More

1
2
3
4
5
6
7
...
»